Care Digital Therapeutics™ (CareDTx™) has designed focused programs to deliver digital therapeutics for patients with multi-morbid disease.
Diabetes-Hypertension
This is the most subscribed integrated program. It is designed for personalized monitoring for individuals living with both diabetes and hypertension.
Obesity-Diabetes
This program assists patients and their treating clinicians to monitor glucose and weight data during therapeutic weight loss GLP-1 treatment.
Metabolic Syndrome
We have designed this program to monitor multiple bio-indicators (ketones, blood pressure, glucose, hemoglobin, cholesterol etc.) specifically for metabolic syndrome affected individuals.

Diabetes-Hypertension Combined Monitoring
Diabetes and hypertension often occur together, significantly increasing the risk of heart disease, stroke, and kidney complications. A person with diabetes and high blood pressure is four times as likely to develop heart disease than someone who does not have either of the conditions.
For individuals living with both diabetes and hypertension, we provide a blood pressure (BP) self-monitoring device with Bluetooth technology, also an innovative glucometer (and a total cholesterol when needed). Remote monitoring of blood pressure, glucose and cholesterol biodata will help identify poor diseases control and trigger early intervention by the treating health professionals.

Metabolic Syndrome Monitoring
Metabolic syndrome (MetS) is a major risk factor for type 2 diabetes and cardiovascular disease. Care digital therapeutics (CareDTx™) provides digital health interventions that provide health and wellness strategies to support lifestyle modification and the long-term management of cardiometabolic disease. Our services analyze the subscriber user health condition and provide tailored health monitoring technology and lifestyle knowledge content to help manage risk factors for MetS and improve their health and wellness.

Diabetes -Obesity weight Loss Monitoring
People with diabetes, particularly type 2, are prone to being overweight and obese. Obesity is a risk factor to developing type 2 diabetes and other metabolic abnormalities such as hyperlipidaemia. This increases the risk of arthrerosclerosis, heart attack, stroke and peripheral arteries disease. The use of GLP-1 tratment for weight loss has shown several health benefits to patients related to a reduction in cardiovascular-kidney-metabolic complications. Care digital therapeutics (CareDTx™) provides a digital health program which includes the remote monitoring of weight loss and several biomarkers (glucose and total cholesterol).